Learn About Congenital Cardiovascular Shunt

What is the definition of Congenital Cardiovascular Shunt?
A cardiovascular shunt is an abnormal pattern of blood circulation between the right and left sides of the heart or between the systemic and pulmonary vessels. A congenital shunt is present at birth. The circulatory system has a normal pathway for blood distribution in which every heart beat provides freshly oxygenated blood to the body. When a shunt is present this normal flow of blood may not occur. There are two main groups of shunts, acyanotic shunts and cyanotic shunts. The most common congenital cardiovascular shunts are acyanotic and known as atrial septal defects. Congenital cardiovascular shunts are the most common congenital heart defects, affecting roughly 1% of all births that have some type of congenital heart problem.
What are the alternative names for Congenital Cardiovascular Shunt?
Intracardiac shunts, right-left shunt, left-right shunt or bidirectional shunt, atrial septal defects, congenital heart defect, congenital heart anomaly
What are the causes of Congenital Cardiovascular Shunt?
A congenital cardiovascular shunt is present at birth and result from abnormal embryo development.
What are the symptoms of Congenital Cardiovascular Shunt?
Symptoms of cardiovascular shunts are dependent on the severity of the abnormal blood flow and the location of the shunt. Sometime the condition is asymptomatic, especially in childhood, although symptoms may appear in adolescence or adulthood. Symptoms of acyanotic shunts: Irregular heartbeats or palpitations Dizziness Shortness of breath and tiring easily Symptoms for more serious cyantonic shunts include: A bluish discoloration of the skin called cyanosis Difficulty breathing Coughing up blood Clubbing of the fingernails or toenails
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Congenital Cardiovascular Shunt?
Treatment depends on the type and location of the shunt and range from clinical observation to surgical intervention. Small acyanotic shunts often do not need treatment and may close on there own over time. Larger acyanotic shunts need to be closed surgically to avoid complications. Cyanotic shunts, which are more serious and have a higher rate of mortality, often require surgery to correct the defect.
Who are the top Congenital Cardiovascular Shunt Local Doctors?
183 High St, 
Newton, NJ 
 6.3 mi

Pavel Tishuk is a Neurologist in Newton, New Jersey. Dr. Tishuk and is rated as an Experienced provider by MediFind in the treatment of Congenital Cardiovascular Shunt. His top areas of expertise are Benign Rolandic Epilepsy, Guillain-Barre Syndrome, Seizures, and Generalized Tonic-Clonic Seizure.

Internal Medicine
Internal Medicine

David Yakobashvili,md,llc

201 Pleasant Hill Rd, 
Chester, NJ 
 22.9 mi

John Neibert is an Internal Medicine provider in Chester, New Jersey. Dr. Neibert has been practicing medicine for over 36 years and is rated as an Experienced provider by MediFind in the treatment of Congenital Cardiovascular Shunt. His top areas of expertise are Acute Pain, Stroke, Rhabdomyolysis, and Apoplexy.

 
 
 
 
Learn about our expert tiers
Learn More
Internal Medicine
Internal Medicine
500 Plaza Ct, Ste B, 
East Stroudsburg, PA 
 23.4 mi

William Kesselring is an Internal Medicine provider in East Stroudsburg, Pennsylvania. Dr. Kesselring and is rated as an Experienced provider by MediFind in the treatment of Congenital Cardiovascular Shunt. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Maturity Onset Diabetes of the Young.

What is the outlook (prognosis) for Congenital Cardiovascular Shunt?
In all cases of congenital cardiovascular shunts close observation and timely intervention are critical. The prognosis ranges from living a normal life to potentially fatal. Acyanotic shunts are less serious than cyanotic shunts and often close on their own over time. Larger ones may require surgery to repair, but if proper treatment is undertaken before the onset of serious symptoms the prognosis for recovery is good. Cyanotic shunts and untreated symptomatic acyanotic shunts have a worse prognosis. If severe pulmonary hypertension develops or if there is permanent damage to the blood vessels in the lungs a heart or lung transplant may be necessary. When severe cyanotic anomalies are present soon after birth immediate surgery is needed in order to increase the chance of survival.
What are the possible complications of Congenital Cardiovascular Shunt?
Most shunts are benign and do not cause complications. In severe cases of cyanotic shunts possible complications can be recurrent infections, pulmonary hypertension, right side heart failure, Eisenmenger syndrome, infections in the heart valves or linings of the heart and disturbances in the heart rhythm. Death is possible in severe cases.
What are the latest Congenital Cardiovascular Shunt Clinical Trials?
The Role of Thiamine on Left Ventricular Structure and Function After Transcatheter Closure Through the Examination of MMP-9 Dan TIMP-1 in Children With Left-to-Right Shunt Congenital Heart Disease

Summary: Currently, research on the effect of thiamine administration during transcatheter closure on the structure and function of the left ventricle by examining levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in children with left to right shunt congenital heart disease has never been carried out in Indonesia, so it is necessary carried out this research. This research w...

Match to trials
Find the right clinical trials for you in under a minute
Get started
OPTImal Treatment of Sinus VENOSUS Defect - Efficacy and Safety of Transcatheter Correction Compared to Surgical Treatment in Patients With Sinus Venosus Defect

Summary: Sinus venosus defect (SVD) accounts for 10% of atrial septal defects and is characterized by an anomalous pulmonary venous return in the superior vena cava associated with a high situated atrial septal defect. Since 2013, transcatheter correction of this congenital heart disease has emerged as a new treatment option. The procedure involves placement of a covered stent in the superior vena cava tha...